Health Reference Series: AIDS Sourcebook

Editor/Author Williams, Angela L.
Publication Year: 2018
Publisher: Omnigraphics, Inc.

Single-User Purchase Price: $95.00
Unlimited-User Purchase Price: $142.50
ISBN: 978-0-7808-1636-7
Category: Health & Medicine - Medicine
Image Count: 28
Book Status: Available
Table of Contents

AIDS Sourcebook, Seventh Edition, provides basic consumer information about the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), including information about the stages of the disease and about how it is transmitted.

Share this

Table of Contents

    • Preface
    • Part I: Basic Information about Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV/AIDS)
    • Chapter 1—Definition and Origin of HIV and AIDS
    • Chapter 2—HIV Stages and Types
    • Section 2.1—The HIV Life Cycle
    • Section 2.2—Stages of HIV Infection
    • Section 2.3—Acute HIV Infection
    • Section 2.4—HIV Drug Resistance
    • Chapter 3—Symptoms of HIV
    • Chapter 4—How HIV Causes AIDS
    • Chapter 5—HIV/AIDS: A Statistical Overview
    • Chapter 6—Impact of HIV on Racial and Ethnic Minorities in the United States
    • Section 6.1—HIV among African Americans
    • Section 6.2—HIV among American Indians and Alaska Natives
    • Section 6.3—HIV among Asians
    • Section 6.4—HIV among Hispanics/Latinos
    • Section 6.5—HIV among Native Hawaiians and Other Pacific Islanders
    • Chapter 7—HIV/AIDS among Specific Populations
    • Section 7.1—HIV among Children and Adolescents
    • Section 7.2—HIV among Women
    • Section 7.3—HIV among Older Adults
    • Section 7.4—HIV among Gay and Bisexual Men
    • Section 7.5—HIV among Transgender People
    • Section 7.6—HIV among Incarcerated Populations
    • Section 7.7—HIV among Sex Workers
    • Part II: HIV/AIDS Transmission, Risk Factors, and Prevention
    • Chapter 8—HIV Transmission: Questions and Answers
    • Chapter 9—Risky Behaviors and HIV
    • Section 9.1—Alcohol, Drugs, and HIV Risk
    • Section 9.2—Injection Drug Use and HIV Risk
    • Section 9.3—Sexual Risk Factors and HIV Transmission
    • Section 9.4—Sexually Transmitted Diseases and HIV Risk
    • Chapter 10—HIV Risk in the Healthcare Setting
    • Section 10.1—Occupational Exposure
    • Section 10.2—Blood Transfusion
    • Section 10.3—Organ Transplantation
    • Chapter 11—HIV/AIDS Risks and Prevention Strategies
    • Chapter 12—HIV/AIDS Prevention
    • Section 12.1—Safer Sex
    • Section 12.2—Circumcision
    • Section 12.3—Syringe Exchange Programs
    • Section 12.4—Harm Reduction to Lessen HIV Risks
    • Chapter 13—Preventing Mother-to-Child Transmission of HIV
    • Section 13.1—HIV Medicines during Pregnancy and Childbirth
    • Section 13.2—Preventing Mother-to- Child Transmission of HIV After Birth
    • Chapter 14—HIV Vaccines and Microbicides
    • Section 14.1—Preventive Vaccines
    • Section 14.2—Microbicides
    • Chapter 15—HIV Prophylaxis
    • Section 15.1—Preexposure Prophylaxis (PrEP)
    • Section 15.2—Long-Acting PrEP
    • Section 15.3—Postexposure Prophylaxis (PEP)
    • Part III: Receiving an HIV/AIDS Diagnosis
    • Chapter 16—HIV Testing
    • Section 16.1—HIV Testing Basics
    • Section 16.2—Frequency of HIV Testing and Time from Infection to Diagnosis Improve
    • Section 16.3—HIV Testing in the United States
    • Section 16.4—HIV Disclosure Policies and Procedures
    • Section 16.5—An Opt-Out Approach to HIV Screening
    • Section 16.6—Counseling for People Diagnosed with HIV
    • Chapter 17—Types of HIV Diagnostic Tests
    • Section 17.1—HIV Diagnostic Tests: An Overview
    • Section 17.2—Rapid Oral HIV Tests
    • Section 17.3—HIV Home Test Kits
    • Chapter 18—Understanding Your Test Results
    • Chapter 19—You and Your HIV/AIDS Healthcare Provider: First Steps
    • Section 19.1—Choosing a Healthcare Provider
    • Section 19.2—Visiting a Healthcare Provider
    • Chapter 20—Just Diagnosed: Next Steps after Testing Positive for HIV
    • Chapter 21—Laboratory Tests
    • Chapter 22—FAQs on Testing and the Window Period
    • Part IV: Treatments and Therapies for HIV/AIDS
    • Chapter 23—Treatment Overview
    • Chapter 24—FAQs on Treatment
    • Chapter 25—Decision Making: To Start Therapy or Not
    • Chapter 26—Antiretroviral Treatment
    • Section 26.1—Starting Anti-HIV Medications
    • Section 26.2—HIV Treatment Regimens
    • Section 26.3—Deciding Which Drugs to Take
    • Chapter 27—HIV/AIDS Treatment Adherence
    • Section 27.1—Importance of Medication Adherence
    • Section 27.2—Following an HIV Regimen: Steps to Take before and after Starting HIV Medicines
    • Chapter 28—HIV/AIDS Treatment Interruptions
    • Chapter 29—HIV/AIDS Treatment Side Effects
    • Section 29.1—Understanding HIV Treatment Side Effects
    • Section 29.2—Diabetes
    • Section 29.3—Hepatotoxicity and Lactic Acidosis
    • Section 29.4—Hyperlipidemia
    • Section 29.5—Lipodystrophy
    • Section 29.6—Osteoporosis
    • Section 29.7—Skin Rash
    • Chapter 30—Other HIV/AIDS Treatment Complications
    • Section 30.1—Drug Interactions
    • Section 30.2—Risk of Muscle Injury
    • Chapter 31—Antiretroviral Treatment Failure and Its Management
    • Chapter 32—Alternative (Complementary) Therapies for HIV/AIDS
    • Chapter 33—Medical Marijuana for HIV/AIDS
    • Chapter 34—HIV/AIDS Treatments in Development
    • Section 34.1—Antiretroviral Drug Discovery and Development
    • Section 34.2—Therapeutic HIV Vaccines
    • Chapter 35—Investigational HIV Drug and Its Role in HIV Treatment
    • Chapter 36—HIV/AIDS Clinical Trials and Research
    • Section 36.1—Basics of Clinical Trials
    • Section 36.2—Clinical Trials for HIV Treatment in Pregnant Women
    • Section 36.3—Combination HIV Prevention Reduces New Infections
    • Section 36.4—HIV Research Activities
    • Section 36.5—Drug Combination Reduces Risk of HIV Infection among Teen Males
    • Section 36.6—Potential Source of HIV Persistence Confirmed
    • Section 36.7—Biomarker Tracks Accelerated HIV-Associated Aging
    • Section 36.8—Experimental Combination Surprises with Anti-HIV Effectiveness
    • Section 36.9—HIV Can Spread Early, Evolve in Patients’ Brains
    • Section 36.10—Starting Antiretroviral Treatment Early Improves Outcomes for HIV-Infected Individuals
    • Chapter 37—Treatment Recommendations for Pediatric HIV Infection
    • Chapter 38—HIV and AIDS Treatment for Pregnant Women
    • Chapter 39—Paying for HIV Care and Treatment
    • Part V: Common Co-Occurring Infections and Complications of HIV/AIDS
    • Chapter 40—Opportunistic Infections and Their Relationship to HIV/AIDS
    • Chapter 41—Preventing Opportunistic Infections
    • Chapter 42—HIV/AIDS and Co-Occurring Bacterial Infections
    • Section 42.1—Mycobacterium avium Complex
    • Section 42.2—Tuberculosis
    • Chapter 43—HIV/AIDS and Co-Occurring Fungal Infections
    • Section 43.1—Risk of Fungal Infections among People with HIV/AIDS
    • Section 43.2—Candidiasis
    • Section 43.3—Cryptococcus neoformans
    • Section 43.4—Coccidioidomycosis
    • Section 43.5—Histoplasmosis
    • Section 43.6—Pneumocystis Pneumonia
    • Chapter 44—HIV/AIDS and Co-Occurring Parasitic Infections
    • Section 44.1—Cryptosporidiosis
    • Section 44.2—Toxoplasmosis
    • Chapter 45—HIV/AIDS and Co-Occurring Viral Infections
    • Section 45.1—Cytomegalovirus
    • Section 45.2—Genital Herpes
    • Section 45.3—Herpes Zoster Virus
    • Section 45.4—Human Papillomavirus
    • Section 45.5—Progressive Multifocal Leukoencephalopathy
    • Section 45.6—Viral Hepatitis
    • Chapter 46—HIV/AIDS and Co-Occurring Cancers
    • Section 46.1—HIV Infection and Cancer Risk
    • Section 46.2—Kaposi Sarcoma
    • Section 46.3—AIDS-Related Lymphoma
    • Chapter 47—Other AIDS-Related Health Concerns
    • Section 47.1—HIV-Associated Neurocognitive Disorders
    • Section 47.2—Oral Health Issues
    • Section 47.3—Kidney Disease
    • Section 47.4—Wasting Syndrome
    • Part VI: Living with HIV Infection
    • Chapter 48—Coping with an HIV/AIDS Diagnosis
    • Chapter 49—Staying Healthy When You Have HIV/AIDS
    • Section 49.1—HIV and Nutrition
    • Section 49.2—HIV and Exercise
    • Section 49.3—Mental Health
    • Section 49.4—HIV, Alcohol, and Drugs
    • Section 49.5—HIV and Smoking
    • Chapter 50—Avoiding Infections When You Have HIV/AIDS
    • Section 50.1—Preventing Exposure
    • Section 50.2—Safe Food and Water
    • Section 50.3—Staying Healthy while Traveling
    • Section 50.4—Vaccinations
    • Chapter 51—Life Issues When You Have HIV/AIDS
    • Section 51.1—Standing Up to HIV-Related Stigma
    • Section 51.2—Employment
    • Section 51.3—Sex and Sexuality and HIV
    • Section 51.4—Aging with HIV/AIDS
    • Chapter 52—HIV/AIDS Status Disclosure
    • Chapter 53—HIV/AIDS Patients and Legal Rights
    • Section 53.1—Your Rights in the Workplace
    • Section 53.2—Laws for Your Welfare
    • Chapter 54—Public Benefits and Housing Options for Persons with HIV
    • Section 54.1—Social Security for People Living with HIV/AIDS
    • Section 54.2—Affordable Care Act for People Living with HIV/AIDS
    • Section 54.3—Housing Options for People with HIV
    • Chapter 55—Caring for Someone with HIV/AIDS
    • Part VII: Additional Help and Information
    • Chapter 56—Glossary of HIV/AIDS-Related Terms
    • Chapter 57—Directory of Organizations for People with HIV/AIDS and Their Families and Friends